JenaValve announced today that it received the green light to begin a new randomized controlled trial for its Trilogy device.

Chevron (CVX) was the most shorted large-cap stock in the Americas in October, according to the latest Shortside Crowdedness ...

The global industrial valves market is on track for significant growth, with a projected valuation exceeding USD 123.05 ...

The company was founded in 2005 and currently boasts 9 million sellers and 96 million active buyers. With over 100 million ...

Valve releases a major Deadlock update for November 2024, bringing new content along with improvements and fixes to enhance ...

The "Mechanical Heart Valves Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" report has been added to ...

Rumors continue to swirl about the possibility of Xbox releasing a handheld, posing questions about what this hypothetical ...

Crane Company's focus on aerospace and process flow drives growth. Read why CR stock offers growth but faces valuation ...

The Hydrogen Electric Research Team at the Korea Electrotechnology Research Institute (KERI) has developed the world's first ...

Recalled Recall, $30 for Windows 10 updates, new Windows bugs, and more stories in this week's Microsoft Weekly news recap.

Here's hoping AMD's upcoming RDNA 4 cards can shake things up a little. Right now, it looks like NVIDIA is only competing ...

New clinical trial data show there is no benefit to waiting when it comes to heart-valve replacement surgery. Other news includes: Ozempic and Wegovy now available, after long shortage; AirPods Pro ...